Principal Financial Group Inc. Sells 226,421 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Principal Financial Group Inc. trimmed its position in Omega Healthcare Investors, Inc. (NYSE:OHI) by 27.5% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 596,404 shares of the real estate investment trust’s stock after selling 226,421 shares during the period. Principal Financial Group Inc. owned about 0.23% of Omega Healthcare Investors worth $24,274,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. UMB Bank n.a. grew its holdings in shares of Omega Healthcare Investors by 353.4% in the third quarter. UMB Bank n.a. now owns 662 shares of the real estate investment trust’s stock valued at $27,000 after acquiring an additional 516 shares in the last quarter. Versant Capital Management Inc purchased a new position in Omega Healthcare Investors in the second quarter worth $26,000. DiNuzzo Private Wealth Inc. bought a new position in Omega Healthcare Investors in the 3rd quarter valued at $33,000. V Square Quantitative Management LLC increased its position in shares of Omega Healthcare Investors by 49.5% during the 3rd quarter. V Square Quantitative Management LLC now owns 976 shares of the real estate investment trust’s stock valued at $40,000 after purchasing an additional 323 shares during the last quarter. Finally, Harbor Capital Advisors Inc. purchased a new stake in shares of Omega Healthcare Investors during the 3rd quarter valued at $53,000. Hedge funds and other institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Stock Down 2.2 %

Shares of NYSE OHI opened at $40.07 on Thursday. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. The company has a market cap of $10.82 billion, a P/E ratio of 29.44, a P/E/G ratio of 1.28 and a beta of 0.99. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $44.42. The business has a 50-day simple moving average of $40.65 and a two-hundred day simple moving average of $36.54.

Omega Healthcare Investors Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Monday, November 4th will be given a $0.67 dividend. The ex-dividend date of this dividend is Monday, November 4th. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.69%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 197.06%.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Wells Fargo & Company restated an “overweight” rating and set a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st. Scotiabank increased their target price on shares of Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. BNP Paribas raised shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a report on Thursday, October 31st. Berenberg Bank initiated coverage on Omega Healthcare Investors in a report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Finally, Truist Financial boosted their target price on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “hold” rating in a research note on Wednesday, September 4th. Seven investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $40.00.

Insider Activity at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the sale, the chief financial officer now directly owns 183,076 shares in the company, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, COO Daniel J. Booth sold 56,725 shares of the company’s stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.25, for a total value of $2,283,181.25. Following the transaction, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of Omega Healthcare Investors stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $40.19, for a total transaction of $905,962.98. Following the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.37% of the stock is owned by corporate insiders.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.